Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Trifilieff

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 23, 2002
Long-term protective and antigen-specific effect of heat-killed Mycobacterium vaccae in a murine model of allergic pulmonary inflammationClaudia Zuany-Amorim, Corinne Manlius, Alexandre Trifilieff, et al.
Radiology|July 24, 2008
Allergen-induced lung inflammation in actively sensitized mice assessed with MR imagingFrançois-Xavier Blé, Catherine Cannet, Stefan Zurbruegg, et al.
Toxicology and Applied Pharmacology|June 1, 2015
Comparing the cardiovascular therapeutic indices of glycopyrronium and tiotropium in an integrated rat pharmacokinetic, pharmacodynamic and safety modelAlexandre Trifilieff, Brian T Ethell, David A Sykes, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 3, 2012
The Influence of receptor kinetics on the onset and duration of action and the therapeutic index of NVA237 and tiotropiumDavid A Sykes, Mark R Dowling, Juliet Leighton-Davies, et al.
Immunology|August 30, 2008
Essential role of phosphoinositide 3-kinase gamma in eosinophil chemotaxis within acute pulmonary inflammationMatthew Thomas, Matthew J Edwards, Elzbieta Sawicka, et al.
European Journal of Pharmacology|July 10, 2007
Effects of PKF242-484 and PKF241-466, novel dual inhibitors of TNF-alpha converting enzyme and matrix metalloproteinases, in a model of intestinal reperfusion injury in miceDanielle G Souza, Flávio Lopes Ferreira, Caio T Fagundes, et al.
European Journal of Immunology|March 2, 2005
Airway inflammation: chemokine-induced neutrophilia and the class I phosphoinositide 3-kinasesMatthew J Thomas, Alexandra Smith, Denise H Head, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 26, 2006
In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of actionCliff Battram, Steven J Charlton, Bernard Cuenoud, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2012
An investigation into the structure-activity relationships associated with the systematic modification of the β(2)-adrenoceptor agonist indacaterolDavid Beattie, David Beer, Michelle E Bradley, et al.
Journal of Medicinal Chemistry|August 20, 2015
Discovery and Optimization of 4-(8-(3-Fluorophenyl)-1,7-naphthyridin-6-yl)transcyclohexanecarboxylic Acid, an Improved PDE4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)Neil J Press, Roger J Taylor, Joseph D Fullerton, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Immunology (Baltimore, Md. : 1950)|July 23, 2002
Long-term protective and antigen-specific effect of heat-killed Mycobacterium vaccae in a murine model of allergic pulmonary inflammationClaudia Zuany-Amorim, Corinne Manlius, Alexandre Trifilieff, et al.
Radiology|July 24, 2008
Allergen-induced lung inflammation in actively sensitized mice assessed with MR imagingFrançois-Xavier Blé, Catherine Cannet, Stefan Zurbruegg, et al.
Toxicology and Applied Pharmacology|June 1, 2015
Comparing the cardiovascular therapeutic indices of glycopyrronium and tiotropium in an integrated rat pharmacokinetic, pharmacodynamic and safety modelAlexandre Trifilieff, Brian T Ethell, David A Sykes, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 3, 2012
The Influence of receptor kinetics on the onset and duration of action and the therapeutic index of NVA237 and tiotropiumDavid A Sykes, Mark R Dowling, Juliet Leighton-Davies, et al.
Immunology|August 30, 2008
Essential role of phosphoinositide 3-kinase gamma in eosinophil chemotaxis within acute pulmonary inflammationMatthew Thomas, Matthew J Edwards, Elzbieta Sawicka, et al.
European Journal of Pharmacology|July 10, 2007
Effects of PKF242-484 and PKF241-466, novel dual inhibitors of TNF-alpha converting enzyme and matrix metalloproteinases, in a model of intestinal reperfusion injury in miceDanielle G Souza, Flávio Lopes Ferreira, Caio T Fagundes, et al.
European Journal of Immunology|March 2, 2005
Airway inflammation: chemokine-induced neutrophilia and the class I phosphoinositide 3-kinasesMatthew J Thomas, Alexandra Smith, Denise H Head, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 26, 2006
In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of actionCliff Battram, Steven J Charlton, Bernard Cuenoud, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2012
An investigation into the structure-activity relationships associated with the systematic modification of the β(2)-adrenoceptor agonist indacaterolDavid Beattie, David Beer, Michelle E Bradley, et al.
Journal of Medicinal Chemistry|August 20, 2015
Discovery and Optimization of 4-(8-(3-Fluorophenyl)-1,7-naphthyridin-6-yl)transcyclohexanecarboxylic Acid, an Improved PDE4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)Neil J Press, Roger J Taylor, Joseph D Fullerton, et al.
Pageof 4